Share on StockTwits

Elizabeth Arden (NASDAQ:RDEN) has received an average rating of “Hold” from the seven ratings firms that are covering the company, reports. Five investment analysts have rated the stock with a hold recommendation, The average 1-year target price among analysts that have updated their coverage on the stock in the last year is $25.20.

A number of research firms have recently commented on RDEN. Analysts at B. Riley cut their price target on shares of Elizabeth Arden from $23.00 to $17.00 in a research note on Wednesday. They now have a “neutral” rating on the stock. Analysts at SunTrust downgraded shares of Elizabeth Arden from a “buy” rating to a “neutral” rating in a research note on Tuesday. They now have a $15.00 price target on the stock, down previously from $35.00.

Shares of Elizabeth Arden (NASDAQ:RDEN) traded up 2.99% on Wednesday, hitting $15.50. The stock had a trading volume of 967,670 shares. Elizabeth Arden has a 52-week low of $14.65 and a 52-week high of $40.40. The stock has a 50-day moving average of $20.62 and a 200-day moving average of $26.. The company has a market cap of $460.3 million and a price-to-earnings ratio of 89.05.

Elizabeth Arden (NASDAQ:RDEN) last posted its quarterly earnings results on Tuesday, August 19th. The company reported ($1.04) earnings per share for the quarter, missing the analysts’ consensus estimate of ($0.34) by $0.70. The company had revenue of $191.72 million for the quarter, compared to the consensus estimate of $241.64 million. During the same quarter in the prior year, the company posted $0.10 earnings per share. The company’s quarterly revenue was down 28.4% on a year-over-year basis. Analysts expect that Elizabeth Arden will post $0.55 EPS for the current fiscal year.

Elizabeth Arden, Inc is a beauty products company with a range of portfolio of fragrance, skin care and cosmetics brands.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.